Cutler Group LP Sarepta Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

27 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	SELL	$93.7 - $141.53 $1.24 Million - $1.87 Million	-13,200 Reduced 83.54%	2,600 $20,000
Q4 2023 Jan 18, 2024	SELL	$67.31 - $124.76 $424,053 - $785,988	-6,300 Reduced 28.51%	15,800 $159,000
Q3 2023 Nov 07, 2023	BUY	$102.5 - $123.59 $461,250 - $556,155	4,500 Added 25.57%	22,100 $468,000
Q2 2023 Jul 18, 2023	SELL	$106.4 - $157.19 $1.26 Million - $1.85 Million	-11,800 Reduced 40.14%	17,600 $339,000
Q1 2023 May 01, 2023	BUY	$117.53 - $155.99 $3.19 Million - $4.23 Million	27,100 Added 1178.26%	29,400 $278,000

Q4 2022 Feb 07, 2023	BUY	$100.86 - $132.13 $10,086 - $13,213	100 Added 4.55%	2,300 $13,000
Q3 2022 Oct 25, 2022	SELL	$75.71 - $119.24 $749,528 - $1.18 Million	-9,900 Reduced 81.82%	2,200 $23,000
Q2 2022 Aug 04, 2022	BUY	$62.69 - $88.44 $363,602 - $512,952	5,800 Added 92.06%	12,100 $74,000
Q1 2022 Apr 14, 2022	SELL	$63.15 - $90.42 $587,295 - $840,906	-9,300 Reduced 59.62%	6,300 $83,000
Q4 2021 Jan 18, 2022	BUY	$77.28 - $99.42 $850,080 - $1.09 Million	11,000 Added 239.13%	15,600 $264,000
Q3 2021 Oct 26, 2021	BUY	$65.97 - $92.48 $52,776 - $73,984	800 Added 21.05%	4,600 $189,000
Q2 2021 Jul 19, 2021	SELL	$69.38 - $86.75 $124,883 - $156,150	-1,800 Reduced 32.14%	3,800 $235,000
Q1 2021 Apr 26, 2021	SELL	$72.25 - $168.95 $3.03 Million - $7.1 Million	-42,000 Reduced 88.24%	5,600 $424,000
Q4 2020 Jan 21, 2021	BUY	$125.56 - $178.74 $4.96 Million - $7.06 Million	39,500 Added 487.65%	47,600 $343,000
Q3 2020 Oct 27, 2020	SELL	$127.12 - $172.34 $966,112 - $1.31 Million	-7,600 Reduced 48.41%	8,100 $217,000
Q2 2020 Jul 22, 2020	BUY	$93.0 - $171.7 $195,300 - $360,570	2,100 Added 15.44%	15,700 $210,000
Q1 2020 May 07, 2020	SELL	$82.38 - $131.64 $617,850 - $987,299	-7,500 Reduced 35.55%	13,600 $599,000
Q4 2019 Feb 06, 2020	BUY	$76.53 - $135.58 $918,360 - $1.63 Million	12,000 Added 131.87%	21,100 $438,000
Q3 2019 Oct 28, 2019	SELL	$72.81 - $156.91 $1.76 Million - $3.8 Million	-24,200 Reduced 72.67%	9,100 $507,000
Q2 2019 Aug 09, 2019	BUY	$112.21 - $151.95 $2.66 Million - $3.6 Million	23,700 Added 246.88%	33,300 $32,000
Q1 2019 May 10, 2019	SELL	$106.67 - $151.68 $714,689 - $1.02 Million	-6,700 Reduced 41.1%	9,600 $96,000
Q4 2018 Feb 05, 2019	SELL	$97.32 - $148.76 $720,168 - $1.1 Million	-7,400 Reduced 31.22%	16,300 $174,000
Q3 2018 Nov 07, 2018	SELL	$115.31 - $161.51 $1.19 Million - $1.66 Million	-10,300 Reduced 30.29%	23,700 $97,000
Q2 2018 Aug 10, 2018	BUY	$71.74 - $153.69 $2.02 Million - $4.32 Million	28,100 Added 476.27%	34,000 $263,000
Q1 2018 May 11, 2018	SELL	$54.02 - $82.27 $826,506 - $1.26 Million	-15,300 Reduced 72.17%	5,900 $29,000
Q4 2017 Jan 17, 2018	SELL	$47.64 - $56.75 $2.1 Million - $2.5 Million	-44,100 Reduced 67.53%	21,200 $21,000
Q3 2017 Oct 17, 2017	BUY	$35.73 - $47.15 $2.33 Million - $3.08 Million	65,300	65,300 $178,000

Others Institutions Holding SRPT

# of Institutions

408

Shares Held

83.7M

Call Options Held

5.27M

Put Options Held

5.94M

Vanguard Group Inc Valley Forge, PA

10.8M
Shares

$203 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$194 Million
0.04% of portfolio
State Street Corp Boston, MA

5.3M
Shares

$99.8 Million
0.0% of portfolio
Erste Asset Management Gmb H Vienna, C4

2.69M
Shares

$50.5 Million
0.49% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.65M
Shares

$49.8 Million
0.07% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account